CIK: 1821074 - Address: C/o Kymera Therapeutics, Inc., 200 Arsenal Yards Blvd., Suite 230, Watertown, MA 02472
9 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

3/4/24 18:12
3/4/24
KYMRKymera Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagJacobs Bruce N.MAOCFOS.d-16541.860-4-3142D
3/3/23 16:30
3/2/23
KYMRKymera Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagJacobs Bruce N.MAOCFOS.d-4231.000-1-1105D
1/14/22 17:01
1/12/22
KYMRKymera Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagJacobs Bruce N.MAOCFOS.d-77851.850-15-4618D
12/3/21 18:43
12/3/21
KYMRKymera Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagJacobs Bruce N.MAOCFOS.d-53653.560-10-3618D
9/3/21 17:57
9/3/21
KYMRKymera Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagJacobs Bruce N.MAOCFOS.d-60160.120-10-587D
6/4/21 16:16
6/3/21
KYMRKymera Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagJacobs Bruce N.MAOCFOS.d-46946.870-10-587D
3/15/21 21:08
3/11/21
KYMRKymera Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagJacobs Bruce N.MAOCFOS.dm-60260.150-10-1000D
3/8/21 20:01
3/8/21
KYMRKymera Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagJacobs Bruce N.MAOCFOS.d-50650.650-10-1000D
3/5/21 17:26
3/3/21
KYMRKymera Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagJacobs Bruce N.MAOCFOS.d-89644.780-20-1000D

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact